300
Participants
Start Date
December 1, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
January 31, 2026
Dexamethasone
Dexamethasone will be administered intravenously at varying times during anesthesia induction to assess the impact of timing on postoperative outcomes. Participants will be randomized into one of three groups: one group will receive dexamethasone before the administration of fentanyl, a second group will receive it after the administration of a muscle relaxant, and a third control group will not receive dexamethasone. This timing variation aims to determine the optimal administration point to improve outcomes, including postoperative nausea, pain, glycemic stability, and hemodynamic response.
University Hospital Center Mohammed VI Tangier, Morocco
UNKNOWN
AABDI Mohammed
OTHER